Home » Topics » Regulatory » Patents

Patents
RSS

Coagulation factor X inhibitors described by Yamanouchi

Aug. 16, 1996

Beta3 agonists reported by Dainippon

Aug. 16, 1996

Sanofi describes fibrinogen antagonists

Aug. 16, 1996

Fibrinogen antagonists claimed by Toyama

Aug. 16, 1996

SKB reports fibrinogen antagonists

Aug. 16, 1996

Corvas discloses thrombin inhibitors

Aug. 16, 1996

Kanebo reports Na+/H+ exchange inhibitors

Aug. 16, 1996

Antihypertensive quinazoline derivatives described by Nippon Chemiphar

Aug. 16, 1996

American Cyanamid claims vasopressin antagonists

Aug. 16, 1996

SKB discloses drugs for IL-8-mediated disorders

Aug. 16, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 14, 2025.
European VCs optimistic for med-tech exit opportunities in 2025
BioWorld MedTech
To say that European investors are optimistic about the outlook for the med-tech sector in 2025 is an understatement. A couple of companies are already listed on...
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for February 14, 2025
European VCs bullish on med-tech investments in 2025
BioWorld MedTech
European companies looking for capital should find the fundraising environment more favorable in 2025. Private med-tech financings in January totaled about $2...
Kura/Kyowa Kirin’s ziftomenib hits phase II endpoints in AML
BioWorld
Kura Oncology Inc. and Kyowa Kirin Co. Ltd.’s selective oral menin inhibitor, ziftomenib, met the primary endpoints in the phase II registrational Komet-001 trial...